This document discusses immobilization of biomolecules on biomaterial surfaces. It begins by explaining that biomaterials must have suitable bulk and surface properties to function in biological environments. Common approaches involve fabricating materials with adequate bulk properties, then modifying the surface to enhance biocompatibility. The document then discusses various biomolecules that can be immobilized on surfaces like proteins, peptides, polysaccharides and describes techniques for covalent and non-covalent immobilization. Specific examples of immobilizing collagen, RGD peptide, hyaluronic acid and other biomolecules on scaffolds are provided to support tissue engineering applications.
A part of nanotechnology. Nanosensors is very hot topic for research. As nanosensor has immense applications in the fields like medical, analysis, research etc. Nanosensor recude the cost and also the time require for analysis.
Nanomaterials in biomedical applicationsumeet sharma
An introduction to emerging technology in medicinal science, "nanodrugs" a fruitful combination of nano-science and medical science. In this presentation, use of nano shells for delivery of drugs to targeted cancer cells has been explained. along with In Vivo and In Vitro studies on use of nanomaterials for biomedical application. For any information please feel free to contact me or refer to the references.
Metallic nanoparticles (MNPs) is a type of nanoparticle which have a metal core composed of inorganic metal or metal oxide that is usually covered with a shell made up of organic or inorganic material or metal oxide.
Surface Plasmon Resonance,
Surface Plasmons:
Plasmons confined to surface (interface) and interact with light resulting in polarities.
Propagating electron density waves occurring at the interface between metal and dielectric.
Surface Plasmon Resonance (SPR) and its ApplicationDr. Barkha Gupta
DR. BARKHA GUPTA
ASSISTANT PROFESSOR (VETERINARY BIOCHEMISTRY)
DEPARTMENT OF VETERINARY PHYSIOLOGY AND BIOCHEMISTRY
POST GRADUATE INSTITUTE OF VETERINARY EDUCATION AND RESEARCH (PGIVER), JAIPUR RAJASTHAN UNIVERSITY OF VETERINARY AND ANIMAL SCIENCES (RAJUVAS), BIKANER
YouTube Channel: Barkha’s Vet Sphere
These slides use concepts from my (Jeff Funk) course entitled analyzing hi-tech opportunities to show how nanotechnology for drug deliver is becoming economically feasible.
Characterization of the adhesive interactions between cells and biomaterialsDr. Sitansu Sekhar Nanda
Biomaterials have been introduced as a means to facilitate cell adhesion and infiltration during the repair or replacement of damaged or diseased tissues.
A part of nanotechnology. Nanosensors is very hot topic for research. As nanosensor has immense applications in the fields like medical, analysis, research etc. Nanosensor recude the cost and also the time require for analysis.
Nanomaterials in biomedical applicationsumeet sharma
An introduction to emerging technology in medicinal science, "nanodrugs" a fruitful combination of nano-science and medical science. In this presentation, use of nano shells for delivery of drugs to targeted cancer cells has been explained. along with In Vivo and In Vitro studies on use of nanomaterials for biomedical application. For any information please feel free to contact me or refer to the references.
Metallic nanoparticles (MNPs) is a type of nanoparticle which have a metal core composed of inorganic metal or metal oxide that is usually covered with a shell made up of organic or inorganic material or metal oxide.
Surface Plasmon Resonance,
Surface Plasmons:
Plasmons confined to surface (interface) and interact with light resulting in polarities.
Propagating electron density waves occurring at the interface between metal and dielectric.
Surface Plasmon Resonance (SPR) and its ApplicationDr. Barkha Gupta
DR. BARKHA GUPTA
ASSISTANT PROFESSOR (VETERINARY BIOCHEMISTRY)
DEPARTMENT OF VETERINARY PHYSIOLOGY AND BIOCHEMISTRY
POST GRADUATE INSTITUTE OF VETERINARY EDUCATION AND RESEARCH (PGIVER), JAIPUR RAJASTHAN UNIVERSITY OF VETERINARY AND ANIMAL SCIENCES (RAJUVAS), BIKANER
YouTube Channel: Barkha’s Vet Sphere
These slides use concepts from my (Jeff Funk) course entitled analyzing hi-tech opportunities to show how nanotechnology for drug deliver is becoming economically feasible.
Characterization of the adhesive interactions between cells and biomaterialsDr. Sitansu Sekhar Nanda
Biomaterials have been introduced as a means to facilitate cell adhesion and infiltration during the repair or replacement of damaged or diseased tissues.
Effect of Surface Engineering on Stem Cells.pdfaman15nanavaty
A thorough review covering the nascent domain of Surface Engineering on Stem Cells. This short review will cover basic details of Stem Cell Engineering and Cell Culture Surface Engineering.
Discussing advances in Magnetic Bead coating technologies - Page 9 & 10 - Article from Joshua Soldo from Australian listed Biotech company Anteo Diagnostics ASX:ADO
Stem cells and nanotechnology in regenerative medicine and tissue engineeringDr. Sitansu Sekhar Nanda
Alexis Carrel, winner of the Nobel Prize in Physiology or Medicine in 1912 and the father of whole-organ transplant, was the first to develop a successful technique for end to end arteriovenous anastomosis in transplantation.
Nanogels are particles composed of physically or chemically cross linked polymer networks that expand in an appropriate solvent. Nanogels are hydrophilic three dimensional networks. Due to their relatively high drug encapsulation ability, consistency, tunable size, effortless preparation, negligible toxicity, and stability in the presence of serum, including stimuli responsiveness, these studies integrate characteristics for topical drug delivery. These are soluble in water and permit immediate drug loading in aqueous media. These are created using a vast array of methods, including photolithographic technique, membrane emulsification, and polymerization methods. Due to the entrapment of nanoparticles in the gel matrix, nanogels used as dermatological preparations have prolonged exposure times on the skin, thereby extending the duration of therapeutic efficacy. B. Karthikeyan | G. Alagumanivasagam "A Review on Nanogels" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-7 | Issue-3 , June 2023, URL: https://www.ijtsrd.com.com/papers/ijtsrd57514.pdf Paper URL: https://www.ijtsrd.com.com/pharmacy/other/57514/a-review-on-nanogels/b-karthikeyan
Recent Advancement and Patents of the Lipid Polymer Hybrid Nanoparticlespeertechzpublication
In recent years, robustness and surface engineering of dosage form made improvement in
pharmacokinetics with decrease in dose of drug. Specifi city with adherence of ligands has now become
the reality as surface modifi cation can easily deceive phagocytic system. Lipid molecules ensures the
release of drug at lymphatic system, entrapment of polymeric nanoparticles in lipoidal core led to the
avoidance of disadvantage of low entrapment effi ciency if use of hydrophobic drug with hydrophobic
polymer becomes essential. Various studies have been published and the best formulations with optimal
In vitro and In vivo results are highlighted in this paper. In this review most advanced researches and
accepted patents were discussed so to act as a medium for getting everything regarding lipid polymer
hybrid particles under one umbrella.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Biomolecules immobilization
1. Immobilization of
biomolecules on the
surface of biomaterials
By: Mohsen Norouzi
MSc Student of Tissue Engineering
Islamic Azad University of Najafabad (IAUN)
1
2. Biomaterials must possess bulk properties that
permit its function in the bio‐environment, but
also the best surface properties.
It is difficult to design materials that fulfill both
needs.
A common approach is to fabricate with
adequate bulk properties followed by a
special treatment to enhance the surface
properties.
Preface
2
3. Preface
The broad interdisciplinary area where properties and
processes at this interface are investigated and biofunctional
surfaces are fabricated is called Biological Surface Science.
Examples:
medical implants in the human body (dental implants, artificial
hip and knee joints, artificial blood vessels and heart valves, etc.)
tissue engineering
biosensors and biochips for diagnosis (DNA‐chips, etc.)(clinical
diagnostics, environmental control, food production)
Bioelectronics (systems to get information storage and processing
) and artificial photosynthesis (clean energy)
biomimetic materials (mimic the functional properties of
biological materials/components in order to achieve new and
better materials; ow friction from the sharkskin or self‐cleaning
character like the lotus leaf )
3
5. Approaches to improve biointerfaces:
reduction of unspecific protein adsorption
enhanced adsorption of specific proteins
material modification by immobilization of cell
recognition motives to obtain controlled
interaction between cells and synthetic substrate
• Using methods like selfassembly (SAMs),
surface modification, photochemical
immobilization or polymer chemistry,
complex surfaces with immobilized
peptides and proteins can be prepared
Preface
5
6. Biomolecules used in precision immobilization
strategies include proteins, lipids, polypeptides,
polynucleotides and polysaccharides
Immobilization techniques range from relatively
low to extremely high specificity.
characteristics of successful precision
engineered biorecognition surfaces:
presence of one ligand site and the receptor‐ligand
affinity
an appropriate surface density of those sites
spatial distribution of the ligands
Preface
6
7. The use of short peptides for surface
biorecognition has proved to be
advantageous over the use of the long
chain native ECM proteins, since the
latter tend to be randomly folded upon
adsorption, being the receptor binding
domains not always sterically
available.
Preface
7
8. Immobilization
Molecules may be immobilized either passively through;
o Hydrophobic
o Ionic interactions
o Covalently by attachment to activated surface groups.
Non-covalent surfaces are effective for many applications;
however, passive adsorption fails in many cases.
Covalent immobilization is often necessary for binding of
molecules that do not adsorb, adsorb very weakly, or adsorb
with improper orientation and conformation to non-covalent
surfaces.
Covalent immobilization may result in better biomolecule
activity, reduced nonspecific adsorption, and greater stability.
8
9. Immobilization
Immobilization reaction should have
several characteristics;
Firstly, the reaction should occur rapidly and
therefore allow the use of low concentrations of
reagents for immobilization.
The chemistry should require little, if any, post-
synthetic modification of ligands before
immobilization to maximize the number of
compounds that can be generated by solution
or solid-phase synthesis and minimize the cost
of these reagents.
Immobilized ligands must be in an oriented
and homogeneous manner.
9
10. Immobilization
The immobilization process should occur
selectively in the presence of common
functional groups, including amines, thiols,
carboxylic acids, and alcohols.
Amino-NH2,
Carboxy-COOH,
Aldehyde-CHO,
Thiol-SH,
Hydroxyl-OH
10
11. Immobilization
Surface density of the ligand should be
optimized.
Low density surface coverage will yield a
correspondingly low frequency.
High surface densities may result steric
interference between the covalently
immobilized ligand molecules, impending
access to the target molecules.
11
12. 1) unhindered binding. 2) inaccessible binding site. 3) hindered
binding site when adjacent site is occupied. 4) restricted access
binding site.
Immobilization
12
13. Immobilization
Correct orientation of the ligand molecules on the surface, and using
a spacer arm are important and critical and makes the ligand
available for the target.
13
14. Proteins are much more sensitive
to their physiological environments
and can easily be degraded or
denaturated by physical or
chemical effects. Protein`s 3-D
confirmation must not change
during immobilization procedure.
DNA molecules are much more
stable then proteins.
It is easier to immobilize DNA
molecules.
Immobilization
14
15. Preparation of Surface for
Biomolecule Immobilization
Modification of the surface to create
functional groups.
Modification of biomolecules for
covalent attachment to the surface.
15
21. Surface engineered scaffolds
Collagen:
major structural component forming the natural ECM of
connective tissues and organs
one of the most established methods for endowing cell
adhesive properties to the scaffolds
Examples:
PLA and PLGA scaffolds chemically grafted with collagen by
plasma treatment have shown enhanced adhesion and
spreading of fibroblasts
Collagen modification by conjugation reactions onto PLA
scaffolds grafted with polymethacrylic acid also has improved
cell spreading and growth for use in cartilage tissue
engineering.
its immunogenicity has limited its applications
21
22. Gelatin:
a good alternative for collagen because of its
absence of antigenicity and ease of handling
at high concentrations
Example:
Gelatin immobilized onto porous scaffolds by
physical entrapment and chemical crosslinking
showed greatly enhanced surface properties on
attachment, proliferation, and ECM deposition of
osteoblasts
Surface engineered scaffolds
22
23. Cell adhesive peptides:
Rather than immobilizing the whole protein, chemical
conjugation of short chain peptide moieties derived from
the cell adhesive proteins onto the polymer surface can be
a much more effective strategy
Advantages of The surface immobilization of short peptides:
higher stability against conformational change
easy controllability of surface density,
orientation more favorable for ligand–receptor interaction and
cell adhesion
minimizing immune responses and infection
Surface engineered scaffolds
23
24. peptide sequences involved in cellular
interactions by receptor binding:
RGD, IKVAV, and YIGSR
RGD sequence: one of the best known foruse in tissue
engineering applications
Examples:
Immobilization of RGD onto 3-D matrices to improve cell
adhesive properties was previously demonstrated in collagen
gels, showing enhanced adherence of murine melanoma cells
RGD, along with other short peptide sequences such as IKVAV,
YIGSR, RNAIAEIIKDI from laminin, and HAV from N-cadherin, was
also used for engineering of neural tissue.
PLA scaffolds modified with RGD by plasma treatment not only
resulted in improved adhesion of the osteoblast-like cells, but
also supported its growth and differentiation
osteoblasts seeded onto the RGD immobilized scaffolds greatly
enhanced mineralization and formation of bone-like tissues
24
26. Hyaluronic acid:
a non-sulfated glycosaminoglycan (GAG), is
a major substance of the gel-like component
in the extracellular matrix of connective
tissues
capable of specific cell interaction via the
CD44 receptor which promotes wound
healing and induces chondrogenesis
Examples:
Chitosan–gelatin composite scaffolds modified with
HA have been shown to increase the adhesion of
fibroblasts
PLGA scaffolds modified with HA supported the
growth of chondrocytes with maintenance of its
original phenotype, showing great potential for
cartilage tissue engineering
26
27. Galactose:
utilized in scaffolds for liver tissue engineering
recognized by mammalian hepatocytes through
the asialoglyco protein receptor leading to
regulation of a degradative pathway I
glycoprotein homeostasis
Examples:
Porous scaffolds immobilized with galactose have been
fabricated to improve hepatocyte attachment, viability,
and metabolic functions. Gelatin sponges modified with
galactose were shown to support hepatocyte adhesion
and function such as release of lactate dehydrogenase
(LDH), albumin secretion, and urea synthesis. Perfusion
culture of hepatocytes with galactose-derivatized PLGA
scaffolds further improved viability and functional
activity of the cells
27
28. Heparin:
intensively studied for growth factor releasing
matrices in tissue engineering.
a highly sulfated GAG constituting the
extracellular matrix, and is known for its specific
interactions with various angiogenic growth
factors
Examples:
Heparin binding has been shown to preserve the
stability and biological activity of the growth factors. A
wide variety of scaffold matrices, including nanofibers,
prepared from collagen, fibrin, chitosan, alginate, PLA
and PLGA, have been incorporated or immobilized with
heparin to achieve sustained release of growth factors
28
38. Basement Material (Substrate):
Synthetic polymer substrates, polystyrene (PS) and poly(lactic-co-
glycolic acid) (PLGA), polydimethylsiloxane (PDMS), silica (Si) and
titanium (Ti).
Linkage Material:
Polydopamine
Chemical/Physical Method:
Dipcoating a biomimetic polymer (PD) thin film onto the polymer
surface followed by conjugation of adhesion peptides and
neurotrophic growth factors to the biomimetic polymer film.
Because amine and thiol groups can be covalently conjugated to a
PD layer via the quinone group, PD coating exhibits latent reactivity
to various nucleophiles with those functional groups
Immobilized Material:
ECM protein-derived adhesion peptides, fibronectin [Arg-Gly-Asp
(RGD)] and laminin [Try-Ile-Gly-Ser-Arg (YIGSR)], and neurotrophic
factors, NGF and GDNF
Goal:
Modification of tissue engineering scaffolds for improving the
efficacy of stem cell therapy by generating physicochemical
stimulation promoting proliferation and differentiation of stem cells
surface modification for efficient and reliable manipulation of
human neural stem cell (NSC) differentiation and proliferation
38
39. Result/Effectiveness:
highly efficient, simple immobilization of neuro trophic growth factors
and adhesion peptides onto polymer substrates.
greatly enhance differentiation and proliferation of human NSCs
(human fetal brain derived NSCs and human induced pluripotent stem
cell derived NSCs) at a level comparable or greater than currently
available animal derived coating materials (Matrigel) with safety issues.
versatile platform technology for developing chemically defined, safe,
functional substrates and scaffolds for therapeutic applications of
human NSCs.
efficient surface immobilization of proteins and peptides to a diverse
range of materials, including polymer scaffolds, ceramic substrates, and
metal devices, for stem cell culture and transplantation.
versatile platform technology for efficient development of biomimetic
substrates and scaffolds that induce desirable stem cell behavior and
enhance stem cell function
39
42. Basement Material (Substrate):
ZrO2, TiZr and Ti with its naturally occurring oxide layer TiO2
Linkage Material:
Specific adsorbing peptides (Pep5 (SHKHGGHKHGGH KHGSSGKG)) are
used as anchor molecules to immobilize oligodesoxynucleotides (ODNs)
on the implant surface (anchor strand, AS)
Chemical/Physical Method:
The BAM is conjugated to a complementary ODN strand (CS) which is
able to hybridize to the AS on the implant surface to immobilize the
BAM. The ODN double strand allows for a controlled release of the BAM
adjustable by the ODN sequence and length.
Immobilized Material:
biologically active molecules (BAMs), e.g. antibiotics or growth
factors immobilize the parathyroid hormone (PTH) fragment 1-34
42
43. Result/Effectiveness:
Successful immobilization of biologically active PTH (1-34)
The high potential of the established surfaces to achieve an increased
osseointegration of variable implants, especially for patients with risk
factors. the development of bioinductive implant surfaces might
increase the healing capacity in the bone, especially for patients with
risk factors such as osteoporosis, where the healing of bone fractures is
disturbed.
The ability of PTH (1-34) to induce the differentiation of osteoblast
precursor cells C2C12 was detected by the quantification of the ALP
activity.
The conjugation of PTH with CS only slightly decreased the Alkaline
phosphatase(ALP) activity, indicating that the biological activity was
almost completely maintained. The application of the immobilization
system on the three materials allows for the modification of the surfaces
with PTH (1-34) as the ALP activity could be increased while
unspecifically bound PTH (1-34) itself showed no effect.
43
46. Basement Material (Substrate):
gold, platinum, glass and titanium
Linkage Material:
Peptide motifs
Chemical/Physical Method:
We synthesized bifunctional quartz-binding peptide QBP1–RGD and
titanium-binding peptide TiBP1–RGD peptides via solid phase peptide
synthesis and immobilizes these peptide conjugates on the surface through
directed assembly in a single step
Immobilized Material:
poly(ethylene glycol) anti-fouling polymer and the integrin-binding
RGD sequence
46
47. Result/Effectiveness:
We successfully imparted cell-resistant properties to gold and platinum
surfaces using gold- and platinum-binding peptides, respectively, in
conjunction with PEG.
several-fold increase in the number and spreading of fibroblast cells on
glass and titanium surfaces using quartz and titanium-binding peptides
in conjunction with the integrin ligand RGD.
Control over the extent of cell–material interactions by relatively simple
and biocompatible surface modification procedures using inorganic
binding peptides as linker molecules.
Targeted assembly proved to be an efficient way of immobilizing large
molecules (i.e. PEG) through, first, coating the inorganic binding
peptides and then performing the conjugation reaction.
Directed assembly, on the other hand, is preferred for the immobilization
of small molecules by synthesizing a single chimeric molecule with bi
functional domains.
Control over the extent of cell–material interactions can be achieved
by relatively simple and biocompatible surface modification procedures
using GEPIs as linker molecules.
QBP1 and the TiBP1 facilitate the immobilization of RGD on both
surfaces while preserving its functionality as a recognition site for cells.
47
50. References:
Prof. Marco Mascini, Immobilization of Biomollecules, Grenoble,
2004.
Laia Francesch de Castro , Surface modification of polymers by
plasma polymerization techniques for tissue engineering, doctorate
thesis, Universitat liull, Barcelona .
Hyun Jung Chung, Tae Gwan Park, Surface engineered and drug
releasing pre-fabricated scaffolds for tissue engineering, Advanced
Drug Delivery Reviews 59 (2007) 249–262.
Tina Micksch et al, A modular peptide-based immobilization system
for ZrO2, TiZr and TiO2 surfaces, Acta Biomaterialia (2014).
Qian Yu et al, Anti-fouling bioactive surfaces, Acta Biomaterialia 7
(2011) 1550–1557.
Dmitriy Khatayevich et al, Biofunctionalization of materials for
implants using engineered peptides, Acta Biomaterialia 6 (2010)
4634–4641.
Kisuk Yang et al, Polydopamine-mediated surface modification of
scaffold materials for human neural stem cell engineering,
Biomaterials 33 (2012) 6952e6964.
50